Specific serologic response to genital human papillomavirus types in patients with vulvar precancerous and cancerous lesions
- 30 April 2005
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 192 (4) , 1073-1083
- https://doi.org/10.1016/j.ajog.2004.09.130
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A Controlled Trial of a Human Papillomavirus Type 16 VaccineNew England Journal of Medicine, 2002
- The serological response to papillomavirusesSeminars in Cancer Biology, 1999
- Natural History of Cervicovaginal Papillomavirus Infection in Young WomenNew England Journal of Medicine, 1998
- Cofactors With Human Papillomavirus in a Population-Based Study of Vulvar CancerJNCI Journal of the National Cancer Institute, 1997
- Human Papillomavirus-Specific Serologic Response in Vulvar NeoplasiaGynecologic Oncology, 1996
- Human Papilloma Virus, Vulvar Dystrophy, and Vulvar Carcinoma: Differential Expression of Human Papillomavirus and Vulvar Dystrophy in the Presence and Absence of Squamous Cell Carcinoma of the VulvaGynecologic Oncology, 1996
- Serum IgG, IgM, and IgA Reactivity to Human Papillomavirus Types 11 and 6 Virus-like Particles in Different Gynecologic Patient GroupsThe Journal of Infectious Diseases, 1995
- Prognostic Significance of Human Papillomavirus DNA in Vulvar CarcinomaObstetrics & Gynecology, 1995
- A Virus-Like Particle Enzyme-Linked Immunosorbent Assay Detects Serum Antibodies in a Majority of Women Infected With Human Papillomavirus Type 16JNCI Journal of the National Cancer Institute, 1994
- Sexually transmitted papillomaviral infectionsAmerican Journal of Obstetrics and Gynecology, 1987